Mirum Pharmaceuticals (MIRM) Capital Expenditures (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Capital Expenditures of $664000.0 for Q1 2026, up 1519.51% year-over-year from $41000.0 in Q1 2025, and up 10.67% quarter-over-quarter from $600000.0 in Q4 2025.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Capital Expenditures (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Capital Expenditures history runs 8 years deep, the most recent figure standing at $664000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 1519.51% year-over-year to $664000.0; the TTM figure through Mar 2026 stood at $1.6 million (up 54.46% YoY), while the FY2025 annual figure was $954000.0, down 3.93% from the prior year.
- Capital Expenditures for Q1 2026 stood at $664000.0, up from $600000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $779000.0 in Q2 2024, with the low at $13000.0 in Q1 2024.
- The 5-year median for Capital Expenditures is $97000.0 (2023), against an average of $214142.9.
- The sharpest annual moves came in 2022 and 2025: Capital Expenditures surged 7966.67% in 2022, then slumped 83.83% in 2025.
- Mirum Pharmaceuticals' Capital Expenditures stood at $242000.0 in 2022, then slumped by 71.9% to $68000.0 in 2023, then plunged by 70.59% to $20000.0 in 2024, then soared by 2900.0% to $600000.0 in 2025, then gained by 10.67% to $664000.0 in 2026.
- Business Quant data shows MIRM's Capital Expenditures at $664000.0 in Q1 2026, $600000.0 in Q4 2025, and $187000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Mirum Pharmaceuticals | 6.40 Bn | 5.96 Bn | 145.90 Mn | 23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23,000.00 |
| Mar 31, 2026 | 664,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 187,000.00 |
| Jun 30, 2025 | 126,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 181,000.00 |
| Jun 30, 2024 | 779,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Jun 30, 2023 | 68,000.00 |
| Mar 31, 2023 | 41,000.00 |
| Dec 31, 2022 | 242,000.00 |
| Sep 30, 2022 | 19,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | 28,000.00 |
| Sep 30, 2020 | 46,000.00 |